Back to Journals » International Journal of Chronic Obstructive Pulmonary Disease » Volume 11 » Issue 1
Original Research
The lung function profile of once-daily tiotropium and olodaterol via Respimat® is superior to that of twice-daily salmeterol and fluticasone propionate via Accuhaler® (ENERGITO® study)
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
29,501 | Dovepress* | 22,978+ | 2,834 | 25,812 | |
PubMed Central* | 6,523 | 2,807 | 9,330 | ||
Totals | 29,501 | 5,641 | 35,142 | ||
*Since 3 February 2016 +Since July 2016 |
Total mentioned | Delicious | Others | |||
---|---|---|---|---|---|
8 | 0 | 0 | 0 | 2 | 6 |
View citations on PubMed Central and Google Scholar